Skip to main content
Log in

Increased whole blood chemiluminescence in patients with Shwachman syndrome: therapy trial with thiamine and α-tocopherol

  • Immunology
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Neutrophils purified from peripheral blood of patients with the Shwachman syndrome show enhanced chemiluminescence (CL) and depressed chemotaxis. Here we present data showing that the increased CL response can be demonstrated by using a whole blood CL assay. This assay is well-suited for studies in infants, because the blood sample volumes needed are small. Increase in CL was most distinct in the initial (1 min) activation induced by N-formyl-methionyl-leucyl-phenylalanine. The 1-min response is considered to derive from extracellular production of oxygen radicals. Such an extracellular oxygen radical production may render the patients susceptible to undue oxidant stress. We therefore treated the patients with two antioxidants, thiamine and α-tocopherol, for 3 months. This supplementation, however, failed to exert any significant effect on either whole blood CL or migration of the patients' neutrophils under agarose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CL:

chemiluminescence

FMLP:

N-formylmethionyl-leucyl-phenylalanine

OZP:

opsonized zymosan particles

PBS:

phosphate-buffered saline

ZTS:

zymosan treated serum

References

  1. Aggett PJ, Harris JT, Harvey BAM, Soothill JE (1979) An inherited defect of neutrophil mobility in Shwachman's syndrome. J Pediatr 94:391–394

    PubMed  Google Scholar 

  2. Aggett PJ, Cavanagh NPC, Matthew DJ, Pincott JR, Sutcliffe J, Harries JT (1980) Shwachman's syndrome. A review of 21 cases. Arch Dis Child 55:331–347

    PubMed  Google Scholar 

  3. Allen RC (1986) Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol 133:449–493

    PubMed  Google Scholar 

  4. Allen RC, Pruitt BA (1982) Humoral-phagocyte axis of immune defense in burn patients. Arch Surg 117:133–140

    PubMed  Google Scholar 

  5. Baehner RL, Boxer LA, Ingraham LM, Butterick C, Haak RA (1982) The influence of vitamin E on human polymorhonuclear cell metabolism and function. Ann NY Acad Sci 393: 237–250

    PubMed  Google Scholar 

  6. Bender JG, Van Epps DE (1983) Analysis of the bimodal chemiluminescence pattern stimulated in human neutrophils by chemotactic factors. Infect Immun 41:1062–1070

    PubMed  Google Scholar 

  7. Boxer LA, Harris RE, Baehner RL (1979) Regulation of membrane peroxidation in health and disease. Pediatrics 64: 713–718

    PubMed  Google Scholar 

  8. Caracciolo F, Citterio F, Bonatti PL, Lippa S, De Sole P (1984) Microbial activity of granulocytes in splenectomized patients. Acta Med Rom 22:196–199

    Google Scholar 

  9. Catignani GL, Biery JG (1983) Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem 29:108–112

    Google Scholar 

  10. Conroy PT, Platt PN, Elliott MJ (1984) A comparison of whole blood and neutrophil chemiluminescence in patients undergoing cardiopulmonary bypass. In: Kricka LJ, Stanley PE, Thorpe GHG, Whitehead TP (eds) Analytical applications of bioluminescence and chemiluminescence. Academic Press, Orlando, pp 369–372

    Google Scholar 

  11. Dahlgren C (1988) Effects on extra- and intracellularly localized, chemoattractant-induced, oxygen radical production of neutrophils following modulation of conditions for ligandreceptor interaction. Inflammation 12:335–349

    PubMed  Google Scholar 

  12. Dahlgren C, Stendahl O (1983) Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect Immun 39:736–741

    PubMed  Google Scholar 

  13. De Sole P, Lippa S, Candido A (1985) Chemiluminescence in chronic myelocytic leukemia: a possible early diagnosis of blast crisis. Haematologia 70:205–211

    Google Scholar 

  14. Eckardt K-U, Eckardt H, Harber MJ, Asscher AW (1986) Analysis of polymorphonuclear leukocyte respiratory burst activity in uremic patients using whole-blood chemiluminescence. Nephron 43:274–278

    PubMed  Google Scholar 

  15. Ganz M, Heberer M, Ernst M, Harder F (1985) Granulocyte chemoluminescence to detect renal transplant rejection. Transplant Proc 27:2532–2533

    Google Scholar 

  16. Graft DF, Mischler E, Farrell PM, Busse WW (1982) Granulocyte chemiluminescence in adolescent patients with cystic fibrosis. Am Rev Respir Dis 125:540–543

    PubMed  Google Scholar 

  17. Gyllenhammer H (1987) Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J Immunol Methods 97:209–213

    PubMed  Google Scholar 

  18. Harmoinen A, Perko M, Grönroos P (1981) Rapid quantitative determination of C-reactive protein using LKB 8600 reaction rate analyzer. Clin Chim Acta 13:117–120

    Google Scholar 

  19. Kanner J, Kinsella JE (1983) Initiation of lipid peroxidation by a peroxidase/hydrogen peroxide/halide system. Lipids 18: 204–210

    PubMed  Google Scholar 

  20. Kappus H (1985) Lipid peroxidation: mechanisms, analysis, enzymology and biological relevance. In: Sies H (ed) Oxidative stress. Academic Press, London, pp 273–310

    Google Scholar 

  21. Kemp T, Schram-Doumont A, Geffel R van, Kram R, Szpirer C (1986) Alteration of N-formyl-methionyl-leucyl-phenylalanine-induced response in cystic fibrosis neutrophils. Pediatr Res 20: 520–526

    PubMed  Google Scholar 

  22. Magaro M, Altomonte L, Zoli A, Mirone L, De Sole P, Di Mario G, Lippa S, Oradei A (1988) Influence of diet with different lipid composition on neutrophil chemiluminescence and disease activity in patients with rheumatoid arthritis. Ann Rheum Dis 47:793–799

    PubMed  Google Scholar 

  23. Repo H, Leirisalo M, Tiilikainen A, Laitinen O (1982) Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA-B27 positive and negative sera. Arthritis Rheum 25:655–661

    PubMed  Google Scholar 

  24. Repo H, Savilahti E, Leirisalo-Repo M (1987) Aberrant phagocyte function in Shwachman syndrome. Clin Exp Immunol 69: 204–212

    PubMed  Google Scholar 

  25. Ristola M (1990) Increased oxygen radical production determined by whole blood chemiluminescence in patients with previous yersinia arthritis. APMIS 98:125–130

    PubMed  Google Scholar 

  26. Ristola M, Repo H (1989) Luminol-enhanced chemiluminescence of whole blood: statistical analysis, and comparison of the responses of different subjects. APMIS 97:503–512

    PubMed  Google Scholar 

  27. Roberts RL, Stiehm ER (1989) Increased phagocytic cell chemiluminescence in patients with cystic fibrosis. Am J Dis Child 143:944–950

    PubMed  Google Scholar 

  28. Ruutu P, Savilahti E, Repo H, Kosunen T (1984) Constant defect in neutrophil locomotion but with age decreasing susceptibility to infection in Shwachman syndrome. Clin Exp Immunol 57:249–255

    PubMed  Google Scholar 

  29. Savilahti E, Rapola J (1984) Frequent myocardial lesions in Shwachman's syndrome. Acta Paediatr Scand 73:642–651

    PubMed  Google Scholar 

  30. Segal AW (1985) Variations on the theme of chronic granulomatous disease. Lancet I:1378–1383

    Google Scholar 

  31. Szüts P, Katona Z, Ilyés M, Szabó I, Csató M (1984) Correction of defective chemotaxis with thiamine in Shwachman-Diamond syndrome. Lancet I:1072–1073

    Google Scholar 

  32. Wielders JPM, Mink CJK (1983) Quantitative analysis of total thiamine in human blood, milk and cerebrospinal fluid by reversed-phase ion-pair high-performance liquid chromatography. J Chromatogr 277:45–56

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ristola, M., Savilahti, E., Leirisalo-Repo, M. et al. Increased whole blood chemiluminescence in patients with Shwachman syndrome: therapy trial with thiamine and α-tocopherol. Eur J Pediatr 150, 173–178 (1991). https://doi.org/10.1007/BF01963560

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01963560

Key words

Navigation